Rapid Novor began in 2015, as three people’s vision to advance life science for better human health. Since then we have commercialized groundbreaking software and chemistry for Monoclonal Antibody Sequencing and Polyclonal Antibody Sequencing. We are the largest privately-funded mass spectrometry proteomics facility in Canada, we have grown a team of over 50 employees and have completed thousands of projects.
Building upon 20 years of Co-Founder and Chief Scientist Dr. Bin Ma’s scientific research and inventions, Rapid Novor’s team continues to push protein sequencing boundaries. Our team comprises world-leading experts in protein chemistry, mass spectrometry and bioinformatics. We constantly innovate and create breakthrough technologies to advance life science. We are committed to reliability throughout everything we do.